Summary of the DEGs in the NDIME‐knockout cells compared with control cells at day 5 of neural differentiation.
Analysis of significant GO terms for genes that were downregulated by at least two‐fold in the NDIME‐knockout cells at day 5 of neural differentiation (hypergeometric test, P < 0.05).
Summary of the DEGs in the MEF2C‐knockdown cells compared with control cells at day 5 of neural differentiation.
Analysis of significant GO terms for genes that were downregulated by at least 2‐fold in the MEF2C‐knockdown cells compared with control cells at day 5 of neural differentiation (hypergeometric test, P < 0.05).
Pathway enrichment analysis for the DEGs in the NDIME‐knockout cells compared with control cells at day 5 of neural differentiation.
Pathway enrichment analysis for the DEGs in the Mef2c‐knockdown cells compared with control cells at day 5 of neural differentiation.
Overlap of DEGs between the NDIME‐knockout cells and the MEF2C‐knockdown cells.
Analysis of significant GO terms for genes that were dysregulated in (G) (hypergeometric test, P < 0.05).
Heatmap illustrating the expression of selected neurectoderm genes and mESCs‐specific genes that were shown as log2 FPKM in Ctrl, NDIME
−/−, shCtrl and shMef2c mESCs at day 5 of neural differentiation. Each lane corresponds to an independent biological sample.
qRT–PCR analysis of representative co‐upregulated and co‐downregulated genes in (G) at day 5 of neural differentiation.
Overlapping between co‐regulated genes in (G) and gene sets of interest (hypergeometric test, P = 0.0174).
Relative expression of selectively downregulated ASD risk genes from the DEGs of the NDIME‐knockout cells compared with control cells at day 5 and from the DEGs of the MEF2C‐knockdown cells compared with control cells at day 5.
= 3. *
‐test).